国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

The Aspirin Monotherapy and Dual Therapy with Aspirin-Clopidogrel in Acute Ischemic Stroke and Transient Ischemic Attack

第一作者:Chong Han

通讯作者:Yongjun Wang

antiplatelet therapy disabling neurologic deficits ischemic stroke NIH Stroke Scale stroke recurrence

基本信息

  • 负责人:Chong Han
  • 数据来源: CNSR-Ⅲ
  • 论文编号:CNSR-Ⅲ20190965
  • 发表时间:2025-04-07

2025-04-07

已发表文章

发表杂志:Journal of the American Heart Association

发表类型: Original Contributions

影响因子(IF): 5.3

PMID: 40194961 Pubmed原文链接 全文下载

主要研究背景及目的

Previous clinical studies have confirmed that aspirin-clopidogrel therapy was superior to aspirin monotherapy in acute non-cardioembolic minor stroke or transient ischemic attack. This study aimed to explore the effectiveness of dual therapy with aspirin-clopidogrel to that aspirin monotherapy in patients with acute non-cardioembolic ischemic stroke from the real world.

方法

All patients were divided into aspirin monotherapy and dual therapy with aspirin and clopidogrel. Chi-square test and one-way ANOVA were used to compare the distribution of baseline categorical variables and continuous variables between the two groups. The proportional hazards regression and propensity score matching were used to analyze the association of antiplatelet therapy and clinical outcome.The multivariate-adjusted HR with their 95% CI for clinical outcomes between the two groups were examined using Cox regression model. Kaplan–Meier product limit method was used to generate survival plots, and the significance of differences between groups was tested by the log-rank test. All analyses were performed with SAS software version 9.1.4. Difference significance was defined with a two-sided alpha level of 5%.

结论

主要结果